Pacific Biosciences of California, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pacific Biosciences of California, Inc. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $0.00.
- Pacific Biosciences of California, Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $0.00.
- Pacific Biosciences of California, Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $0.00.
- Pacific Biosciences of California, Inc. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $189.20M.
- Pacific Biosciences of California, Inc. stock issued during period, value, new issues for fiscal 2023 was $189.20M.
- Pacific Biosciences of California, Inc. stock issued during period, value, new issues for fiscal 2021 was $294.85M, a 57.48% increase from fiscal 2020.
- Pacific Biosciences of California, Inc. stock issued during period, value, new issues for fiscal 2020 was $187.23M.
- Pacific Biosciences of California, Inc. stock issued during period, value, new issues for fiscal 2018 was $97.53M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $189.20M 10-K · filed 2026-02-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | |
| 2023-03-31 | $189.20M 10-Q · filed 2024-05-09 | |
| 2021-12-31 | $294.85M 10-K · filed 2024-02-28 | |
| 2020-12-31 | $93.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $187.23M 10-K · filed 2023-02-28 |
| 2020-09-30 | $93.60M 10-Q · filed 2021-11-05 | |
| 2018-12-31 | $97.53M 10-K · filed 2021-02-26 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | |
| 2018-03-31 | $32.86M 10-Q · filed 2019-05-03 | |
| 2016-12-31 | $58.20M 10-K · filed 2017-03-06 | |
| 2016-03-31 | $3.00M 10-Q · filed 2016-08-04 | |
| 2015-12-31 | $29.10M 10-K · filed 2017-03-06 | |
| 2014-12-31 | $38.02M 10-K · filed 2017-03-06 | |
| 2013-12-31 | $19.93M 10-K · filed 2016-03-11 | |
| 2010-12-31 | $210.78M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |